ACET vs AME · $75.7M cap vs P/E 30, rev $7.40B
Adicet Bio Inc (ACET) versus Ametek Inc (AME) — a side-by-side from cached financials, not a winner call.
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
ACET does not have a complete income-statement cache yet.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
ACET currently screens at market cap $75.7M. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Not investment advice. Open the ACET and AME stock pages for the full models.
Not investment advice.